First Page | Document Content | |
---|---|---|
![]() Date: 2013-12-04 21:15:58Biology Interferon beta-1a Pfizer Anatomy Interferon beta-1b Autoimmune diseases Neurological disorders Therapies under investigation for multiple sclerosis Treatment of multiple sclerosis Multiple sclerosis Cytokines Immune system | Add to Reading List |
![]() | Quarterly newsletter of the MS Trust Open Door MayAlso in this issueDocID: 1aIBR - View Document |
![]() | Microsoft Word - stc_information_packDocID: 13Q2D - View Document |
![]() | Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity iDocID: 10jxE - View Document |
![]() | Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS inDocID: Xydz - View Document |
![]() | Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS inDocID: Wu9v - View Document |